Quest Laboratories Limited (NSE:QUESTLAB)
India · Delayed Price · Currency is INR 90.00
+3.70 (4.29%)
Nov 11, 2026, 1:04 PM IST
Quest Laboratories Revenue
In the fiscal year ending March 31, 2026, Quest Laboratories had annual revenue of 1.12B INR with 7.56% growth. Quest Laboratories had revenue of 324.05M in the quarter ending March 31, 2026, a decrease of -30.32%. That makes Quest Laboratories the 36,590th largest company in the world by revenue and 3,144th in India.
Revenue
1.12B
Revenue Growth
+7.56%
P/S Ratio
1.32
Revenue / Employee
11.30M
Employees
99
Market Cap
1.47B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.12B | 78.56M | 7.56% |
| Mar 31, 2025 | 1.04B | 214.03M | 25.92% |
| Mar 31, 2024 | 825.63M | 209.22M | 33.94% |
| Mar 31, 2023 | 616.41M | 21.57M | 3.63% |
| Mar 31, 2022 | 594.84M | 291.20M | 95.91% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 10.69B |
| Accent Microcell | 3.85B |
| Infinium Pharmachem | 1.90B |
| Zenith Drugs | 1.71B |
| Sotac Pharmaceuticals | 1.01B |
| Sunrest Lifescience | 708.33M |
| Vilin Bio Med | 422.63M |
| Medicamen Organics | 226.83M |